Sodium Nitroprusside in Early Course Schizophrenia

NCT04986072 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Difficulty with recruiting subjects for the study

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Sodium Nitroprusside
DRUG: 5% Dextrose solution

Sponsor

Beth Israel Deaconess Medical Center